Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2m-free heavy chains

European Journal of Immunology

Volumn 45, Issue 8, 2015, Pages 2356-2364

  Tremante, Elisa ^a   Lo Monaco, Elisa ^a   Ingegnere, Tiziano ^a   Sampaoli, Camilla ^a   Fraioli, Rocco ^a   Giacomini, Patrizio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

B; C; Conformation; HLA A; HLA E; MAbs; 2 microglobulin ( 2m)

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; MONOCLONAL ANTIBODY; BETA 2 MICROGLOBULIN; EPITOPE; HLA ANTIGEN CLASS 1; HLA-E ANTIGEN;

ALLELE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENSITOMETRY; EPITOPE MAPPING; FLOW CYTOMETRY; HEAVY CHAIN; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; WESTERN BLOTTING; CELL LINE; CHEMISTRY; HUMAN; IMMUNOLOGY; PROTEIN FOLDING;

ANTIBODIES, MONOCLONAL; BETA 2-MICROGLOBULIN; CELL LINE; EPITOPE MAPPING; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; PROTEIN FOLDING;

EID: 84938953062     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545446     Document Type: Article

References (34)

1. Rodgers, J. and Cook, R., MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 2005. 5: 459-471.
2. Ulbrecht, M., Kellermann, J., Johnson, J. P. and Weiss, E. H., Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J. Exp. Med. 1992. 176: 1083-1090.
3. Braud, V. M., Jones, E. Y. and McMichael, A., The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 1997. 27: 1164-1169.
4. Neisig, A., Melief, C. J. M. and Neefjes, J. J., Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 1998. 160: 171-179.
5. Setini, A., Beretta, A., De Santis, C., Meneveri, R., Martayan, A., Mazzilli, M. C., Appella, E. et al., Distinctive features of the α1 domain α helix of HLA-C heavy chains free of β2-microglobulin. Hum. Immunol. 1996. 46: 69-81.
6. 2m and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 2008. 181: 5442-5450.
7. 2m. Hum. Immunol. 1997. 53: 23-33.
8. Ravindranath, M. H., Taniguchi, M., Chen, C. W., Ozawa, M., Kaneku, H., El-Awar, N., Cai, J. and Terasaki, P. I., HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol. Immunol. 2010. 47: 1121-1131.
9. Ravindranath, M. H., Kaneku, H., El-Awar, N., Morales-Buenrostro, L. E. and Terasaki, P. I., Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera. J. Immunol. 2010. 185: 1935-1948.
10. Ravindranath, M. H., Pham, T., El-Awar, N., Kaneku, H. and Terasaki, P. I., Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. Mol. Immunol. 2011. 48: 423-430.
11. Apps, R., Qi, Y., Carlson, J. M., Chen, H., Gao, X., Thomas, R., Yuki, Y. et al., Influence of HLA-C expression level on HIV control. Science 2013. 340: 87-91.
12. Benevolo, M., Mottolese, M., Tremante, E., Rollo, F., Diodoro, M. G., Ercolani, C., Sperduti, I. et al., High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J. Transl. Med. 2011. 9: 184.
13. Tremante, E., Ginebri, A., Lo Monaco, E., Benassi, B., Frascione, P., Grammatico, P., Cappellacci, S. et al., A melanoma immune response signature including Human Leukocyte Antigen-E. Pigment Cell Melanoma Res. 2014. 27: 103-112.
14. Lo Monaco, E., Tremante, E., Cifaldi, L., Fruci, D. and Giacomini, P., HLA-E and the origin of immunogenic self HLA epitopes. Mol. Immunol. 2010. 47: 1661-1662; author reply 1163-1664.
15. Ravindranath, M. H. and El-Awar, N., HLA-E monoclonal antibody MEM-E/02 binds to discontinuous but shared peptide sequences on HLA B & C heavy chains not treated by acid. Mol. Immunol. 2010. 47: 1663-1664.
16. King, A., Boocock, C., Sharkey, A. M., Gardner, L., Beretta, A., Siccardi, A. G. and Loke, Y. W., Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 1996. 156: 2068-2076.
17. Lo Monaco, E., Tremante, E., Cerboni, C., Melucci, E., Sibilio, L., Zingoni, A., Nicotra, M. R. et al., Human Leukocyte Antigen E contributes to protect tumor cells from lysis by natural killer cells. Neoplasia 2011. 13: 822-830.
18. Gooden, M., Lampen, M., Jordanova, E. S., Leffers, N., Trimbos, J. B., van der Burg, S. H., Nijman, H. and van Hall, T., HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8(+) T lymphocytes. Proc. Natl. Acad. Sci. USA 2011. 108: 10656-10661.
19. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998. 160: 4951-4960.
20. Parham, P., Barnstable, C. J. and Bodmer, W. F., Use of monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J. Immunol. 1979. 23: 342-349.
21. Kaiser, B. K., Pizarro, J. C., Kerns, J. and Strong, R. K., Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. USA 2008. 105: 6696-6701.
22. Braud, V. M., Allan, D. S. J., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1998. 8: 1-10.
23. Polakova, K., Bennink, J. R., Yewdell, J. W., Bystricka, M., Bandzuchova, E. and Russ, G., Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum. Immunol. 2003. 64: 256-264.
24. Jones, D. C., Kosmoliaptsis, V., Apps, R., Lapaque, N., Smith, I., Kono, A., Chang, C. et al., HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J. Immunol. 2011. 186: 2990-2997.
25. Goodridge, J. P., Burian, A., Lee, N. and Geraghty, D. E., HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J. Immunol. 2013. 191: 3553-3562.
26. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. and Geraghty, D., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
27. Hoare, H., Sullivan, L., Pietra, G., Clements, C., Lee, E., Ely, L., Beddoe, T. et al., Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 2006. 7: 256-264.
28. Mage, M. G., Dolan, M. A., Wang, R., Boyd, L. F., Revilleza, M. J., Robinson, H., Natarajan, K. et al., The peptide-receptive transition state of MHC class I molecules: insight from structure and molecular dynamics. J. Immunol. 2012. 189: 1391-1399.
29. 2m is fixed during de novo synthesis and irreversible by exchange or dissociation. J. Immunol. 1989. 142: 2751-2758.
30. Lo Monaco, E., Tremante, E., Biswas, P., Cranage, M. P., Zipeto, D., Beretta, A. and Giacomini, P., Comment on "Influence of HLA-C expression level on HIV control". Science 2013. 341: 1175.
31. Tibensky, D., DeMars, R., Holowachuk, E. W. and Delovitch, T. L., Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. J. Immunol. 1989. 143: 348-355.
32. Falk, K., Rötzschke, O., Grahovac, B., Schendel, D., Stevanovic, S., Gnau, V., Jung, G. et al., Allele specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 1993. 90: 12005-12009.
33. Stadler, V., Felgenhauer, T., Beyer, M., Fernandez, S., Leibe, K., Guttler, S., Groning, M. et al., Combinatorial synthesis of peptide arrays with a laser printer. Angew. Chem. Int. Ed. Engl. 2008. 47: 7132-7135.
34. Mack, S. J., Cano, P., Hollenbach, J. A., He, J., Hurley, C. K., Middleton, D., Moraes, M. E. et al., Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens 2013. 81: 194-203.